Cell Therapy-North America Market Status and Trend Report 2013-2023
Report Summary
Cell Therapy-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cell Therapy industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Cell Therapy 2013-2017, and development forecast 2018-2023
Main market players of Cell Therapy in North America, with company and product introduction, position in the Cell Therapy market
Market status and development trend of Cell Therapy by types and applications
Cost and profit status of Cell Therapy, and marketing status
Market growth drivers and challenges
The report segments the North America Cell Therapy market as:
North America Cell Therapy Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Cell Therapy Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Nanotechnology
Natural Substances
North America Cell Therapy Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Scientific Research
Hospital
Other
North America Cell Therapy Market: Players Segment Analysis (Company and Product introduction, Cell Therapy Sales Volume, Revenue, Price and Gross Margin):
Dendreon
Mesoblast
Vericel
AlloCure
Amorcyte
Anterogen
Antibe Therapeutics
Astellas Pharma
Athersys
Avita Medical
AxoGen
Bellicum Pharmaceuticals
BioCardia
BIOCELLULAR THERAPIES
Biogen Idec
Bio-Tissue
BIOTIME
BioTissue Technologies
BrainStorm Cell Therapeutics
Bluebird Bio
Bone Therapeutics
Caladrius
Capricor Therapeutics
CellBioMed
Celgene
Cell Medica
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Cell Therapy-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cell Therapy industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Cell Therapy 2013-2017, and development forecast 2018-2023
Main market players of Cell Therapy in North America, with company and product introduction, position in the Cell Therapy market
Market status and development trend of Cell Therapy by types and applications
Cost and profit status of Cell Therapy, and marketing status
Market growth drivers and challenges
The report segments the North America Cell Therapy market as:
North America Cell Therapy Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Cell Therapy Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Nanotechnology
Natural Substances
North America Cell Therapy Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Scientific Research
Hospital
Other
North America Cell Therapy Market: Players Segment Analysis (Company and Product introduction, Cell Therapy Sales Volume, Revenue, Price and Gross Margin):
Dendreon
Mesoblast
Vericel
AlloCure
Amorcyte
Anterogen
Antibe Therapeutics
Astellas Pharma
Athersys
Avita Medical
AxoGen
Bellicum Pharmaceuticals
BioCardia
BIOCELLULAR THERAPIES
Biogen Idec
Bio-Tissue
BIOTIME
BioTissue Technologies
BrainStorm Cell Therapeutics
Bluebird Bio
Bone Therapeutics
Caladrius
Capricor Therapeutics
CellBioMed
Celgene
Cell Medica
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF CELL THERAPY
1.1 Definition of Cell Therapy in This Report
1.2 Commercial Types of Cell Therapy
1.2.1 Nanotechnology
1.2.2 Natural Substances
1.3 Downstream Application of Cell Therapy
1.3.1 Scientific Research
1.3.2 Hospital
1.3.3 Other
1.4 Development History of Cell Therapy
1.5 Market Status and Trend of Cell Therapy 2013-2023
1.5.1 South America Cell Therapy Market Status and Trend 2013-2023
1.5.2 Regional Cell Therapy Market Status and Trend 2013-2023
CHAPTER 2 SOUTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Cell Therapy in South America 2013-2017
2.2 Consumption Market of Cell Therapy in South America by Regions
2.2.1 Consumption Volume of Cell Therapy in South America by Regions
2.2.2 Revenue of Cell Therapy in South America by Regions
2.3 Market Analysis of Cell Therapy in South America by Regions
2.3.1 Market Analysis of Cell Therapy in Brazil 2013-2017
2.3.2 Market Analysis of Cell Therapy in Argentina 2013-2017
2.3.3 Market Analysis of Cell Therapy in Venezuela 2013-2017
2.3.4 Market Analysis of Cell Therapy in Colombia 2013-2017
2.3.5 Market Analysis of Cell Therapy in Others 2013-2017
2.4 Market Development Forecast of Cell Therapy in South America 2018-2023
2.4.1 Market Development Forecast of Cell Therapy in South America 2018-2023
2.4.2 Market Development Forecast of Cell Therapy by Regions 2018-2023
CHAPTER 3 SOUTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole South America Market Status by Types
3.1.1 Consumption Volume of Cell Therapy in South America by Types
3.1.2 Revenue of Cell Therapy in South America by Types
3.2 South America Market Status by Types in Major Countries
3.2.1 Market Status by Types in Brazil
3.2.2 Market Status by Types in Argentina
3.2.3 Market Status by Types in Venezuela
3.2.4 Market Status by Types in Colombia
3.2.5 Market Status by Types in Others
3.3 Market Forecast of Cell Therapy in South America by Types
CHAPTER 4 SOUTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Cell Therapy in South America by Downstream Industry
4.2 Demand Volume of Cell Therapy by Downstream Industry in Major Countries
4.2.1 Demand Volume of Cell Therapy by Downstream Industry in Brazil
4.2.2 Demand Volume of Cell Therapy by Downstream Industry in Argentina
4.2.3 Demand Volume of Cell Therapy by Downstream Industry in Venezuela
4.2.4 Demand Volume of Cell Therapy by Downstream Industry in Colombia
4.2.5 Demand Volume of Cell Therapy by Downstream Industry in Others
4.3 Market Forecast of Cell Therapy in South America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF CELL THERAPY
5.1 South America Economy Situation and Trend Overview
5.2 Cell Therapy Downstream Industry Situation and Trend Overview
CHAPTER 6 CELL THERAPY MARKET COMPETITION STATUS BY MAJOR PLAYERS IN SOUTH AMERICA
6.1 Sales Volume of Cell Therapy in South America by Major Players
6.2 Revenue of Cell Therapy in South America by Major Players
6.3 Basic Information of Cell Therapy by Major Players
6.3.1 Headquarters Location and Established Time of Cell Therapy Major Players
6.3.2 Employees and Revenue Level of Cell Therapy Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 CELL THERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Dendreon
7.1.1 Company profile
7.1.2 Representative Cell Therapy Product
7.1.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Dendreon
7.2 Mesoblast
7.2.1 Company profile
7.2.2 Representative Cell Therapy Product
7.2.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Mesoblast
7.3 Vericel
7.3.1 Company profile
7.3.2 Representative Cell Therapy Product
7.3.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Vericel
7.4 AlloCure
7.4.1 Company profile
7.4.2 Representative Cell Therapy Product
7.4.3 Cell Therapy Sales, Revenue, Price and Gross Margin of AlloCure
7.5 Amorcyte
7.5.1 Company profile
7.5.2 Representative Cell Therapy Product
7.5.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Amorcyte
7.6 Anterogen
7.6.1 Company profile
7.6.2 Representative Cell Therapy Product
7.6.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Anterogen
7.7 Antibe Therapeutics
7.7.1 Company profile
7.7.2 Representative Cell Therapy Product
7.7.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Antibe Therapeutics
7.8 Astellas Pharma
7.8.1 Company profile
7.8.2 Representative Cell Therapy Product
7.8.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Astellas Pharma
7.9 Athersys
7.9.1 Company profile
7.9.2 Representative Cell Therapy Product
7.9.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Athersys
7.10 Avita Medical
7.10.1 Company profile
7.10.2 Representative Cell Therapy Product
7.10.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Avita Medical
7.11 AxoGen
7.11.1 Company profile
7.11.2 Representative Cell Therapy Product
7.11.3 Cell Therapy Sales, Revenue, Price and Gross Margin of AxoGen
7.12 Bellicum Pharmaceuticals
7.12.1 Company profile
7.12.2 Representative Cell Therapy Product
7.12.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Bellicum Pharmaceuticals
7.13 BioCardia
7.13.1 Company profile
7.13.2 Representative Cell Therapy Product
7.13.3 Cell Therapy Sales, Revenue, Price and Gross Margin of BioCardia
7.14 BIOCELLULAR THERAPIES
7.14.1 Company profile
7.14.2 Representative Cell Therapy Product
7.14.3 Cell Therapy Sales, Revenue, Price and Gross Margin of BIOCELLULAR THERAPIES
7.15 Biogen Idec
7.15.1 Company profile
7.15.2 Representative Cell Therapy Product
7.15.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Biogen Idec
7.16 Bio-Tissue
7.17 BIOTIME
7.18 BioTissue Technologies
7.19 BrainStorm Cell Therapeutics
7.20 Bluebird Bio
7.21 Bone Therapeutics
7.22 Caladrius
7.23 Capricor Therapeutics
7.24 CellBioMed
7.25 Celgene
7.26 Cell Medica
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CELL THERAPY
8.1 Industry Chain of Cell Therapy
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF CELL THERAPY
9.1 Cost Structure Analysis of Cell Therapy
9.2 Raw Materials Cost Analysis of Cell Therapy
9.3 Labor Cost Analysis of Cell Therapy
9.4 Manufacturing Expenses Analysis of Cell Therapy
CHAPTER 10 MARKETING STATUS ANALYSIS OF CELL THERAPY
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Cell Therapy in This Report
1.2 Commercial Types of Cell Therapy
1.2.1 Nanotechnology
1.2.2 Natural Substances
1.3 Downstream Application of Cell Therapy
1.3.1 Scientific Research
1.3.2 Hospital
1.3.3 Other
1.4 Development History of Cell Therapy
1.5 Market Status and Trend of Cell Therapy 2013-2023
1.5.1 South America Cell Therapy Market Status and Trend 2013-2023
1.5.2 Regional Cell Therapy Market Status and Trend 2013-2023
CHAPTER 2 SOUTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Cell Therapy in South America 2013-2017
2.2 Consumption Market of Cell Therapy in South America by Regions
2.2.1 Consumption Volume of Cell Therapy in South America by Regions
2.2.2 Revenue of Cell Therapy in South America by Regions
2.3 Market Analysis of Cell Therapy in South America by Regions
2.3.1 Market Analysis of Cell Therapy in Brazil 2013-2017
2.3.2 Market Analysis of Cell Therapy in Argentina 2013-2017
2.3.3 Market Analysis of Cell Therapy in Venezuela 2013-2017
2.3.4 Market Analysis of Cell Therapy in Colombia 2013-2017
2.3.5 Market Analysis of Cell Therapy in Others 2013-2017
2.4 Market Development Forecast of Cell Therapy in South America 2018-2023
2.4.1 Market Development Forecast of Cell Therapy in South America 2018-2023
2.4.2 Market Development Forecast of Cell Therapy by Regions 2018-2023
CHAPTER 3 SOUTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole South America Market Status by Types
3.1.1 Consumption Volume of Cell Therapy in South America by Types
3.1.2 Revenue of Cell Therapy in South America by Types
3.2 South America Market Status by Types in Major Countries
3.2.1 Market Status by Types in Brazil
3.2.2 Market Status by Types in Argentina
3.2.3 Market Status by Types in Venezuela
3.2.4 Market Status by Types in Colombia
3.2.5 Market Status by Types in Others
3.3 Market Forecast of Cell Therapy in South America by Types
CHAPTER 4 SOUTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Cell Therapy in South America by Downstream Industry
4.2 Demand Volume of Cell Therapy by Downstream Industry in Major Countries
4.2.1 Demand Volume of Cell Therapy by Downstream Industry in Brazil
4.2.2 Demand Volume of Cell Therapy by Downstream Industry in Argentina
4.2.3 Demand Volume of Cell Therapy by Downstream Industry in Venezuela
4.2.4 Demand Volume of Cell Therapy by Downstream Industry in Colombia
4.2.5 Demand Volume of Cell Therapy by Downstream Industry in Others
4.3 Market Forecast of Cell Therapy in South America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF CELL THERAPY
5.1 South America Economy Situation and Trend Overview
5.2 Cell Therapy Downstream Industry Situation and Trend Overview
CHAPTER 6 CELL THERAPY MARKET COMPETITION STATUS BY MAJOR PLAYERS IN SOUTH AMERICA
6.1 Sales Volume of Cell Therapy in South America by Major Players
6.2 Revenue of Cell Therapy in South America by Major Players
6.3 Basic Information of Cell Therapy by Major Players
6.3.1 Headquarters Location and Established Time of Cell Therapy Major Players
6.3.2 Employees and Revenue Level of Cell Therapy Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 CELL THERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Dendreon
7.1.1 Company profile
7.1.2 Representative Cell Therapy Product
7.1.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Dendreon
7.2 Mesoblast
7.2.1 Company profile
7.2.2 Representative Cell Therapy Product
7.2.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Mesoblast
7.3 Vericel
7.3.1 Company profile
7.3.2 Representative Cell Therapy Product
7.3.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Vericel
7.4 AlloCure
7.4.1 Company profile
7.4.2 Representative Cell Therapy Product
7.4.3 Cell Therapy Sales, Revenue, Price and Gross Margin of AlloCure
7.5 Amorcyte
7.5.1 Company profile
7.5.2 Representative Cell Therapy Product
7.5.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Amorcyte
7.6 Anterogen
7.6.1 Company profile
7.6.2 Representative Cell Therapy Product
7.6.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Anterogen
7.7 Antibe Therapeutics
7.7.1 Company profile
7.7.2 Representative Cell Therapy Product
7.7.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Antibe Therapeutics
7.8 Astellas Pharma
7.8.1 Company profile
7.8.2 Representative Cell Therapy Product
7.8.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Astellas Pharma
7.9 Athersys
7.9.1 Company profile
7.9.2 Representative Cell Therapy Product
7.9.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Athersys
7.10 Avita Medical
7.10.1 Company profile
7.10.2 Representative Cell Therapy Product
7.10.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Avita Medical
7.11 AxoGen
7.11.1 Company profile
7.11.2 Representative Cell Therapy Product
7.11.3 Cell Therapy Sales, Revenue, Price and Gross Margin of AxoGen
7.12 Bellicum Pharmaceuticals
7.12.1 Company profile
7.12.2 Representative Cell Therapy Product
7.12.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Bellicum Pharmaceuticals
7.13 BioCardia
7.13.1 Company profile
7.13.2 Representative Cell Therapy Product
7.13.3 Cell Therapy Sales, Revenue, Price and Gross Margin of BioCardia
7.14 BIOCELLULAR THERAPIES
7.14.1 Company profile
7.14.2 Representative Cell Therapy Product
7.14.3 Cell Therapy Sales, Revenue, Price and Gross Margin of BIOCELLULAR THERAPIES
7.15 Biogen Idec
7.15.1 Company profile
7.15.2 Representative Cell Therapy Product
7.15.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Biogen Idec
7.16 Bio-Tissue
7.17 BIOTIME
7.18 BioTissue Technologies
7.19 BrainStorm Cell Therapeutics
7.20 Bluebird Bio
7.21 Bone Therapeutics
7.22 Caladrius
7.23 Capricor Therapeutics
7.24 CellBioMed
7.25 Celgene
7.26 Cell Medica
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CELL THERAPY
8.1 Industry Chain of Cell Therapy
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF CELL THERAPY
9.1 Cost Structure Analysis of Cell Therapy
9.2 Raw Materials Cost Analysis of Cell Therapy
9.3 Labor Cost Analysis of Cell Therapy
9.4 Manufacturing Expenses Analysis of Cell Therapy
CHAPTER 10 MARKETING STATUS ANALYSIS OF CELL THERAPY
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
